Aventis Pharmaceuticals, the US unit of Aventis Pharma AG, is launchingan e-business strategy with two new initiatives to target physicians. Through two separate agreements, Aventis gains access to a network of mobile prescribing (m-prescribing) devices distributed by ParkStone Medical Information Systems, as well as to electronic video detailing (e-detailing) services offered by iPhysicianNet.
"Through these partnerships, Aventis gains new means of providing valuable information to physicians," according to Michelle Runge, vice president and head of the firm's US e-business team.
Aventis also notes that m-prescribing is expected to dramatically change the way physicians practice medicine. Currently, just 20% of US doctors are using handheld devices and it is projected that number will increase to 75% by 2004.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze